Regeneron Pharmaceuticals (REGN) News Today → The AI Stock that’s Disrupting Every Industry (From StockEarnings) (Ad) Free REGN Stock Alerts $937.61 +34.13 (+3.78%) (As of 05/2/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineRegeneron Pharmaceuticals Q1 Earnings Transcriptmarketbeat.com - May 3 at 7:13 AMShhh! 3 Secret Pharma Stocks Flying Below Wall Street's Radarinvestorplace.com - May 3 at 6:15 AMGeorge Yancopoulos Sells 16,848 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Stockamericanbankingnews.com - May 3 at 4:06 AMRegeneron’s stock climbs 4% as analyst look past earnings miss to focus on pipelinemsn.com - May 3 at 12:58 AMLoring Wolcott & Coolidge Fiduciary Advisors LLP MA Has $78.56 Million Stock Position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)marketbeat.com - May 2 at 10:00 PMRegeneron Pharmaceuticals Targets Quality Weight Loss In Latest Obesity Innovationmsn.com - May 2 at 7:57 PMRegeneron's blockbuster eye drug posts weaker sales due to inventory impactmsn.com - May 2 at 7:57 PMRegeneron's Q1 Results Came Up a Bit Shortfool.com - May 2 at 7:57 PMRegeneron Pharmaceuticals misses top-line and bottom-line estimates; updates FY24 outlookmsn.com - May 2 at 2:53 PMRegeneron Pharmaceuticals Inc (REGN) Q1 2024 Earnings: Challenges and Opportunities Amidst ...finance.yahoo.com - May 2 at 2:53 PMRegeneron Reverses On Better-Than-Feared Eylea Sales As Patent Expiration Loomsfinance.yahoo.com - May 2 at 2:53 PMREGN Stock Earnings: Regeneron Pharmaceuticals Misses EPS, Misses Revenue for Q1 2024investorplace.com - May 2 at 12:03 PMRegeneron: Q1 Earnings Snapshotsfgate.com - May 2 at 8:03 AMRegeneron Pharmaceuticals Q1 Profit Decreases, misses estimatesmarkets.businessinsider.com - May 2 at 8:03 AMRegeneron’s stock dips after earnings fall short of estimatesmsn.com - May 2 at 8:03 AMRegeneron misses profit estimates on weaker Eylea and Dupixent salesreuters.com - May 2 at 6:39 AMRegeneron Reports First Quarter 2024 Financial and Operating Resultsglobenewswire.com - May 2 at 6:30 AMInsider Selling: Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Insider Sells 16,848 Shares of Stockinsidertrades.com - May 2 at 5:50 AMSummit Financial LLC Has $7.03 Million Stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)marketbeat.com - May 1 at 6:53 PMVan ECK Associates Corp Has $56.51 Million Position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)marketbeat.com - April 30 at 11:46 AMRegeneron Pharmaceuticals (NASDAQ:REGN) Downgraded to "Buy" at StockNews.comamericanbankingnews.com - April 30 at 2:30 AMRegeneron Pharmaceuticals (NASDAQ:REGN) Rating Lowered to Buy at StockNews.commarketbeat.com - April 30 at 2:29 AMEYLEA® HD (aflibercept) Injection 8 mg Presentations at ARVO Reinforce Sustained and Clinically Meaningful Outcomes in Serious Retinal Diseasesglobenewswire.com - April 29 at 7:00 AMTruist Financial Corp Sells 8,062 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)marketbeat.com - April 29 at 6:52 AMRussell Investments Group Ltd. Has $106.32 Million Position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)marketbeat.com - April 28 at 12:26 PMRegeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Sold by PGGM Investmentsmarketbeat.com - April 27 at 5:38 PMAnalysts Are Bullish on Top Healthcare Stocks: Regeneron (REGN), Gilead Sciences (GILD)markets.businessinsider.com - April 26 at 12:58 PMRegeneron Pharmaceuticals (NASDAQ:REGN) PT Raised to $1,030.00 at TD Cowenamericanbankingnews.com - April 26 at 4:46 AMPrentiss Smith & Co. Inc. Trims Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)marketbeat.com - April 25 at 8:52 PMWells Fargo Reaffirms Their Buy Rating on Regeneron (REGN)markets.businessinsider.com - April 25 at 10:12 AMRegeneron and Mammoth Biosciences Collaborate to Pursue Next-Generation CRISPR-Based Gene Editing for Multiple Diseasesmarkets.businessinsider.com - April 25 at 10:12 AMRegeneron, Mammoth in pact to develop CRISPR-based gene editing therapiesmsn.com - April 25 at 10:12 AMJennifer Doudna co-founded Peninsula biotech lands CRISPR gene-editing pact with Regeneronbizjournals.com - April 25 at 10:12 AMUPDATE 1-AbbVie's skin disease drug found to be more effective than Regeneron's Dupixent in studyfinance.yahoo.com - April 25 at 10:12 AMAbbVie's skin disease drug found to be more effective than Regeneron's Dupixent in studyreuters.com - April 25 at 8:48 AMRegeneron to collaborate on gene editing therapies with Doudna-founded Mammothreuters.com - April 25 at 7:14 AMRegeneron Pharmaceuticals (REGN) Scheduled to Post Earnings on Thursdayamericanbankingnews.com - April 25 at 1:28 AMRegeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Purchased by Alaska Permanent Fund Corpmarketbeat.com - April 24 at 5:16 PMRegeneron Pharmaceuticals (NASDAQ:REGN) Price Target Raised to $1,030.00 at TD Cowenmarketbeat.com - April 24 at 1:57 PMRegeneron to Showcase Progress in Advancing Novel Investigational Treatment Approaches for a Broad Range of Solid Tumors and Blood Cancers at ASCOglobenewswire.com - April 24 at 10:05 AMCantor Fitzgerald Brokers Raise Earnings Estimates for Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)americanbankingnews.com - April 24 at 2:24 AMNew York State Common Retirement Fund Has $131.92 Million Position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)marketbeat.com - April 23 at 12:28 PMFY2024 EPS Estimates for Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Raised by Analystmarketbeat.com - April 23 at 6:14 AMLoring Wolcott & Coolidge Fiduciary Advisors LLP MA Buys 17,529 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)marketbeat.com - April 22 at 11:39 PMRegeneron to Highlight Advances in Genetic Medicine Research at American Society of Gene and Cell Therapy (ASGCT)globenewswire.com - April 22 at 5:54 PMShikiar Asset Management Inc. Cuts Stock Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)marketbeat.com - April 21 at 5:00 PMabrdn plc Buys 186,215 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)marketbeat.com - April 20 at 12:10 PMRegeneron Pharmaceuticals Insiders Sell US$26m Of Stock, Possibly Signalling Cautionfinance.yahoo.com - April 19 at 12:59 PMRegeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Holdings Lifted by Xponance Inc.marketbeat.com - April 19 at 10:17 AMThe Law Offices of Frank R. Cruz Announces Investigation of Regeneron Pharmaceuticals, Inc. (REGN) on Behalf of Investorsbusinesswire.com - April 17 at 2:15 PM Get Regeneron Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for REGN and its competitors with MarketBeat's FREE daily newsletter. Email Address The Long-Awaited End of America Update (Ad)A 995% Gain Last Time We Shared this "Election Secret" It's a straightforward way to come out on top no matter who wins this November… It's not cryptos, or options, and anyone can do it. Click here to find out for free. REGN Media Mentions By Week REGN Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. REGN News Sentiment▼0.410.35▲Average Medical News Sentiment REGN News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. REGN Articles This Week▼2714▲REGN Articles Average Week Get Regeneron Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for REGN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Vertex Pharmaceuticals News Bristol-Myers Squibb News GSK News Sanofi News Zoetis News Pfizer News Takeda Pharmaceutical News Royalty Pharma News BeiGene News Catalent News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:REGN) was last updated on 5/3/2024 by MarketBeat.com Staff From Our PartnersBiden to Launch “FedNOW” [Move Your Money Now]Priority GoldThe AI stock to buy right nowStockEarningsHave You Seen Elon’s New A.I. Device? (Picture Inside)InvestorPlaceCould Your Accounts Be Frozen?Allegiance GoldUrgent Nvidia WarningAltimetryThe A.I. story nobody is telling you (Read ASAP)TradeSmith$5,000 Gold?Stansberry ResearchBitcoin Rockets To Record High But Buy THIS InsteadParadigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Regeneron Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
